EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Management of SGLT-2 Inhibitors in the Perioperative Period: Withhold or Continue?

Zack Pittack

British Journal of Hospital Medicine · 2025

DOI: 10.12968/hmed.2024.0611 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, 2025. Verfasst von Zack Pittack. Beteiligte Einrichtung: Department of Anaesthesia, Northumbria Healthcare NHS Foundation Trust, Newcastle-Upon-Tyne, UK. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2, Perioperative Care, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are commonly prescribed in diabetes mellitus and increasingly for cardiorenal protection. They carry the risk of euglycaemic diabetic ketoacidosis (eDKA). Guidelines around the perioperative handling of these medications are limited and some evidence suggests that withholding them can lead to more surgical complications and poorer glycaemic control. This article gives an overview of arguments for and against withholding SGLT-2 inhibitors in the perioperative period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsDiabetes Mellitus, Type 2Perioperative CareHypoglycemic AgentsHumansDiabetic KetoacidosisPerioperative PeriodPostoperative Complications

Stichwörter der Autor:innen

SGLT-2 inhibitorseuglycaemic diabetic ketoacidosisperioperative period

Substanzen

Sodium-Glucose Transporter 2 InhibitorsHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Anaesthesia, Northumbria Healthcare NHS Foundation Trust, Newcastle-Upon-Tyne, UK.

Zitieren

APA

Pittack, Z. (2025). Management of SGLT-2 Inhibitors in the Perioperative Period: Withhold or Continue?. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2024.0611

Vancouver

Pittack Z. Management of SGLT-2 Inhibitors in the Perioperative Period: Withhold or Continue?. British Journal of Hospital Medicine. 2025. doi:10.12968/hmed.2024.0611

BibTeX
@article{Pittack2025,
  author = {Pittack, Zack},
  title = {Management of SGLT-2 Inhibitors in the Perioperative Period: Withhold or Continue?},
  journal = {British Journal of Hospital Medicine},
  year = {2025},
  doi = {10.12968/hmed.2024.0611}
}
Kostenlos starten →